Martínez F, Johansson L, Nowak P. "一种的合成方法" [P]. European Patent, EP 3032236 A1, 2015-10-23.
Sørensen M, Schröder R, Nowak P. "Method for the Synthesis of n-(2-Acetamidoethyl)-4-amino-1,2,5-oxadiazole-3-carboxamide" [P]. European Patent, EP 3413170 A1, 2020-11-26.
发明人周伟,徐明华,何建平. "A Process for Preparing High-Purity n-(2-Acetamidoethyl)-4-amino-1,2,5-oxadiazole-3-carboxamide" [P]. 中国发明专利, 专利号 CN 116405848 B, 授权公告日 2018-06-14.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2015, 83, (6), 4308-4320.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2016, 987, 7693-7721.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of n-(2-Acetamidoethyl)-4-amino-1,2,5-oxadiazole-3-carboxamide Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2010, 2008, (9), 3317-3329.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2016, 409, (5), 6241-6250.